Joseph Bush1, Christopher A Langley2, Duncan Jenkins3, Jaspal Johal4, Clair Huckerby5. 1. Pharmacy Practice, Aston Pharmacy School, Aston University, Birmingham, UK. 2. Pharmacy Law and Practice, Aston Pharmacy School, Aston University, Birmingham, UK. 3. Pharmaceutical Public Health, Dudley Clinical Commissioning Group, Brierley Hill Health and Social Care Centre, Brierley Hill, UK. 4. Dudley Clinical Commissioning Group, Brierley Hill Health and Social Care Centre, Brierley Hill, UK. 5. Medicines Optimisation Lead, Dudley Clinical Commissioning Group, Brierley Hill Health and Social Care Centre, Brierley Hill, UK.
Abstract
OBJECTIVES: This aim of this research was to characterise the breadth and volume of activity conducted by clinical pharmacists in general practice in Dudley Clinical Commissioning Group (CCG), and to provide quantitative estimates of both the savings in general practitioner (GP) time and the financial savings attributable to such activity. METHODS: This descriptive observational study retrospectively analysed quantitative data collected by Dudley CCG concerning the activity of clinical pharmacists in GP practices during 2015. KEY FINDINGS: Over the 9-month period for which data were available, the 5.4 whole time equivalent clinical pharmacists operating in GP practices within Dudley CCG identified 23 172 interventions. Ninety-five per cent of the interventions identified were completed within the study period saving the CCG in excess of £1 000 000. During the 4 months for which resource allocation data were available, the clinical pharmacists saved 628 GP appointments plus an additional 647 h that GPs currently devote to medication review and the management of repeat prescribing. CONCLUSIONS: This research suggests that clinical pharmacists in general practice in Dudley CCG are able to deliver clinical interventions efficiently and in high volume. In doing so, clinical pharmacists were able to generate considerable financial returns on investment. Further work is recommended to examine the effectiveness and cost-effectiveness of clinical pharmacists in general practice in improving outcomes for patients.
OBJECTIVES: This aim of this research was to characterise the breadth and volume of activity conducted by clinical pharmacists in general practice in Dudley Clinical Commissioning Group (CCG), and to provide quantitative estimates of both the savings in general practitioner (GP) time and the financial savings attributable to such activity. METHODS: This descriptive observational study retrospectively analysed quantitative data collected by Dudley CCG concerning the activity of clinical pharmacists in GP practices during 2015. KEY FINDINGS: Over the 9-month period for which data were available, the 5.4 whole time equivalent clinical pharmacists operating in GP practices within Dudley CCG identified 23 172 interventions. Ninety-five per cent of the interventions identified were completed within the study period saving the CCG in excess of £1 000 000. During the 4 months for which resource allocation data were available, the clinical pharmacists saved 628 GP appointments plus an additional 647 h that GPs currently devote to medication review and the management of repeat prescribing. CONCLUSIONS: This research suggests that clinical pharmacists in general practice in Dudley CCG are able to deliver clinical interventions efficiently and in high volume. In doing so, clinical pharmacists were able to generate considerable financial returns on investment. Further work is recommended to examine the effectiveness and cost-effectiveness of clinical pharmacists in general practice in improving outcomes for patients.
Authors: V M Sloeserwij; A C M Hazen; D L M Zwart; A J Leendertse; J M Poldervaart; A A de Bont; J J de Gier; M L Bouvy; N J de Wit Journal: Br J Clin Pharmacol Date: 2019-07-25 Impact factor: 4.335
Authors: Nikesh Parekh; Khalid Ali; John Graham Davies; Jennifer M Stevenson; Winston Banya; Stephen Nyangoma; Rebekah Schiff; Tischa van der Cammen; Jatinder Harchowal; Chakravarthi Rajkumar Journal: BMJ Qual Saf Date: 2019-09-16 Impact factor: 7.035
Authors: Niels Peek; Wouter T Gude; Richard N Keers; Richard Williams; Evangelos Kontopantelis; Mark Jeffries; Denham L Phipps; Benjamin Brown; Anthony J Avery; Darren M Ashcroft Journal: PLoS Med Date: 2020-10-13 Impact factor: 11.069